Call us for Counseling - 9580048004, For Support - 8860807050.  

Tags Current Affairs

Antiviral drug MK-4482

Date: 19 April 2021 Tags: Miscellaneous


Experimental anti-viral drug MK-4482 has showed a strong ability to decrease viral levels and lungs damage against SARS-CoV-2 infection.



The study was conducted in infected hamsters by US National Institutes of Health. It shows a lot of promise to treat serious infection.



  • MK-4482 drug was delivered orally to humans in trials in comparison to remdesivir, which is given intravenously.

  • The use of the drug MK-4482 was found effective in hamsters when they were given the drug 12 hours before or 12 hours after getting infected by SARS-CoV-2 virus.

  • The results suggest that the drug can be used to treat serious cases of the infection as a standalone or in combination with other drugs.


The study

  • The animals used in the treatment groups had 100 times less infections in their lungs than the control group of animals.

  • Previous forms of study have also indicated that MK-4482 was indeed effective at stopping the viruses from replicating.

Notice (8): Undefined variable: quizpole [ROOT/plugins/Studyiq/src/Template/Pages/tagdetails.ctp, line 161]